Avid Bioservices Inc (CDMO)

[thealias2002]

I respectfully disagree. Management is the main issue here, but, Bavi has been around quite a while now. Companies either come out with something new and are purchased/partnered or they take a lonely road. The newest issue to contend with seems to be the market. Bavi does have good results with chemo per the p2 trials (if reliable), etc., however,.....the market wants immuno drugs and we have insufficient external data.

How long to generate that data? Will the investigatory partnerships be deemed reliable enough (if they generate positive data) or will a FDA approved trial need to be run?

LOTS of questions.